You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

CLINICAL TRIALS PROFILE FOR LEUKINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for LEUKINE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002594 ↗	Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors	Completed	National Cancer Institute (NCI)	Phase 2	1994-09-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so that they stop growing or die. bone marrow transplantation and peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by bone marrow transplantation and/or peripheral stem cell transplantation in treating patients who have recurrent medulloblastoma or CNS germ cell tumors.
NCT00002594 ↗	Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors	Completed	Children's Oncology Group	Phase 2	1994-09-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so that they stop growing or die. bone marrow transplantation and peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by bone marrow transplantation and/or peripheral stem cell transplantation in treating patients who have recurrent medulloblastoma or CNS germ cell tumors.
NCT00003093 ↗	Combination Chemotherapy in Treating Children With Neuroblastoma	Completed	National Cancer Institute (NCI)	Phase 3	1988-03-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Combination chemotherapy plus surgery may be an effective treatment for neuroblastoma. PURPOSE: This phase III trial is studying how well combination chemotherapy followed by surgery works in treating young patients with neuroblastoma.
NCT00003093 ↗	Combination Chemotherapy in Treating Children With Neuroblastoma	Completed	Children's Oncology Group	Phase 3	1988-03-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Combination chemotherapy plus surgery may be an effective treatment for neuroblastoma. PURPOSE: This phase III trial is studying how well combination chemotherapy followed by surgery works in treating young patients with neuroblastoma.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for LEUKINE

Condition Name

Chart
Table

Condition Name for LEUKINE
Intervention	Trials
Lymphoma	7
Recurrent Neuroblastoma	6
Breast Cancer	6
Crohn Disease	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for LEUKINE
Intervention	Trials
Leukemia	13
Neuroblastoma	13
Breast Neoplasms	11
Lymphoma	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LEUKINE

Trials by Country

Map
Table

Trials by Country for LEUKINE
Location	Trials
United States	636
Canada	61
Australia	48
United Kingdom	22
New Zealand	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for LEUKINE
Location	Trials
Texas	38
California	30
New York	29
Pennsylvania	22
Ohio	21
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LEUKINE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for LEUKINE
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	11
Phase 2/Phase 3	1
[disabled in preview]	66
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for LEUKINE
Clinical Trial Phase	Trials
Completed	55
Terminated	16
Recruiting	13
[disabled in preview]	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LEUKINE

Sponsor Name

Chart
Table

Sponsor Name for LEUKINE
Sponsor	Trials
National Cancer Institute (NCI)	40
Bayer	14
M.D. Anderson Cancer Center	11
[disabled in preview]	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for LEUKINE
Sponsor	Trials
Other	128
Industry	62
NIH	51
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.